Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07483658
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed prostate adenocarcinoma.
* Prior radical prostatectomy with detectable PSA (≥0.2 ng/mL).
* No evidence of distant metastasis (confirmed via bone scan and CT/MRI or TEP-PSMA if PSA is above 0.5 ng /ml).
* Patient with Nodal recurrence within the pelvis are eligible
* ECOG performance status 0-2.
* Age ≥ 18 years.
* Adequate baseline renal, hepatic, and hematologic function.
Exclusion Criteria:
* Prior pelvic radiotherapy.
* Macroscopic local relapse on imaging
* Presence of metastatic disease.
* Active inflammatory bowel disease or other GI conditions predisposing to radiation toxicity.
* Uncontrolled comorbidities affecting study participation.
* Prior systemic therapy for recurrent prostate cancer (except ADT within 6 months).
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT07483658
Study Brief:
Protocol Section:
NCT07483658